Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb 20;104(8):2791-6.
doi: 10.1073/pnas.0611158104. Epub 2007 Feb 12.

Prion species barrier between the closely related yeast proteins is detected despite coaggregation

Affiliations

Prion species barrier between the closely related yeast proteins is detected despite coaggregation

Buxin Chen et al. Proc Natl Acad Sci U S A. .

Abstract

Prions are self-perpetuating and, in most cases, aggregation-prone protein isoforms that transmit neurodegenerative diseases in mammals and control heritable traits in yeast. Prion conversion requires a very high level of identity of the interacting protein sequences. Decreased transmission of the prion state between divergent proteins is termed "species barrier" and was thought to occur because of the inability of divergent prion proteins to coaggregate. Species barrier can be overcome in cross-species infections, e.g., from "mad cows" to humans. We studied the counterparts of yeast prion protein Sup35, originated from three different species of the Saccharomyces sensu stricto group and exhibiting the range of prion domain divergence that overlaps with the range of divergence observed among distant mammalian species. All three proteins were capable of forming a prion in Saccharomyces cerevisiae, although prions formed by heterologous proteins were usually less stable than the endogenous S. cerevisiae prion. Heterologous Sup35 proteins coaggregated in the S. cerevisiae cells. However, in vivo cross-species prion conversion was decreased and in vitro polymerization was cross-inhibited in at least some heterologous combinations, thus demonstrating the existence of prion species barrier. Moreover, the barrier between the S. cerevisiae protein and its Saccharomyces paradoxus and Saccharomyces bayanus counterparts was asymmetric both in vivo and in vitro. Our data show that a decreased cross-species prion transmission does not necessarily correlate with a lack of cross-species coaggregation, suggesting that species-specificity of prion transmission is controlled at the level of conformational transition rather than coaggregation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
S. paradoxus and S. bayanus Sup35 proteins retain prion-forming abilities despite divergence of PrD sequences. (A) Structural and functional organization of the S. sensu stricto Sup35 proteins. N, M, C, QN, and OR refer to the Sup35N, Sup35M, Sup35C, QN-rich stretch, and ORs, respectively. Numbers correspond to amino acid positions; the percentage of amino acid identity to S. cerevisiae is shown for each region of S. paradoxus and S. bayanus proteins individually. For sequence alignment of the Sup35N regions, see SI Fig. 5. Data are from refs. – and the Yeast Genome Database (www.yeastgenome.org), confirmed by sequencing of our PCR-amplified clones. (B and C) Transient overproduction of S. paradoxus Sup35 protein (Sup35SP) or the Sup35NMSP-GFP fusion protein (B), or transient overproduction of S. bayanus Sup35 protein (Sup35SB) (C) induces prion formation in the [psi PIN+] S. cerevisiae strains bearing the SUP35SP (B) or SUP35SB (C) gene instead of SUP35SC. Empty plasmids pmCUP-GFP (B) or pRS316GAL (C) were used as controls. Prion formation was detected by growth on −Ade medium after induction on PCUP1-SUP35SP or PCUP1-SUP35NMSP-GFP constructs on the medium with 100 μM CuSO4 (B) or PGAL-SUP35SB construct on Gal medium (C). (D) Sup35SP generates both strong and weak prion variants, whereas Sup35SB generates only weak prion variants in S. cerevisiae, as judged from the efficiency of ade1–14 suppression reflected by growth on −Ade. Note that both strong and weak variants of the Sup35SP prion show low mitotic stability (see SI Table 2). Plates were photographed after 5 (B), 8 (C), and 7 (D) days of incubation.
Fig. 2.
Fig. 2.
Coaggregation of heterologous Sup35 proteins in S. cerevisiae. (A) The S. cerevisiae [PSI+] strain simultaneously expressing both endogenous (Sup35SC) and heterologous (Sup35SP or Sup35SB) proteins shows all of the Sup35-reacting material in the pellet (P) after centrifugation at 39,000 × g, whereas the isogenic [psi] strain retains a fraction of Sup35 in the supernatant (S). Shift of Sup35SB to pellet can be monitored directly because of its lower molecular weight, compared with Sup35SC. T, total lysate. (B) The chimeric Sup35NMSP-GFP protein, expressed from the PCUP1 promoter in the presence of background levels (2 μM) of CuSO4, shifts to pellet together with the endogenous Sup35SC protein in the [PSI+] extract, in contrast to the [psi] extract. Designations are as in A. (C–F) The GFP-tagged NM fragments of Sup35SC (C), Sup35SP (D), and Sup35SB (E), but not the GFP-tagged Sup35NM fragment of P. methanolica (Sup35NMPM-GFP, F), colocalize with the aggregated clumps of RFP-tagged Sup35SC in the S. cerevisiae [PSI+] cells. GFP- and RFP-tagged constructs were expressed from the PCUP1 and PGAL promoters, respectively, in the Gal+Raf medium supplemented with 150 μM CuSO4. In each case, >100 cells containing both GFP and RFP aggregates were scored, and the percentage of cells with colocalization is shown. Scale bars are indicated.
Fig. 3.
Fig. 3.
Prion species barrier between the closely related Sup35 proteins in the plasmid shuffle assay. Designations SC, SP, and SB refer to the SUP35SC, SUP35SP, and SUP35SB genes, respectively. Donor [PSI+] sup35Δ strain with SC gene on the CEN plasmid, which grew on −Ade before the experiment (stage I), was transformed individually with CEN plasmids either bearing the intact SC, SP, or SB genes (A) or containing the chimeric constructs composed of the SUP35MC region of S. cerevisiae (MCSC) and SUP35N regions (N) of various origins (B). In B, reconstructed SUP35 gene with SUP35NSC origin was used as a control. In contrast to intact or reconstructed SUP35SC, heterologous genes (A) or chimeric genes with the heterologous N regions (B) inhibited suppression of ade1–14 by [PSI+], as judged by decreased growth on −Ade medium selective for both plasmids (stage II). After elimination of the original SC plasmid (stage III), all colonies with the new SC plasmid or reconstructed NSC-MCSC plasmid retained [PSI+], whereas most or all colonies with SP, SB, or chimeric plasmids containing NSP or NSB lost [PSI+], as seen by growth/no growth on −Ade medium, respectively. Numbers of [PSI+] and [psi] colonies obtained are given in each case.
Fig. 4.
Fig. 4.
In vitro polymerization of the S. sensu stricto Sup35NM protein fragments. The purified (His)6-tagged Sup3NM regions of S. cerevisiae (Sup35NMSC or SC, A), S. paradoxus (Sup35NMSP or SP, B), and S. bayanus (Sup35NMSB or SB, C) spontaneously polymerize in the nondenaturing conditions after a certain lag period, as detected by a decrease of the monomeric fraction remaining soluble in SDS and capable of entering the SDS/PAGE gel without boiling. Boiled samples where all protein enters the gel are shown in each case as controls. Addition of preformed polymers at the ratio of 1:20 leads to the following results: Sup35NMSC promotes polymerization of Sup35NMSC (A) and Sup35NMSP (B) but delays polymerization of Sup35NMSB (C); Sup35NMSP promotes polymerization of Sup35NMSP (B) but delays polymerization of both Sup35NMSC (A) and Sup35NMSB (C); Sup35NMSB promotes polymerization of both Sup35NMSC (A) and Sup35NMSB (C) but delays polymerization of Sup35NMSP (B).

Similar articles

Cited by

References

    1. Lansbury PT, Jr, Caughey B. Chem Biol. 1995;2:1–5. - PubMed
    1. Weissmann C. Nat Rev Microbiol. 2004;2:861–871. - PubMed
    1. Prusiner SB. Proc Natl Acad Sci USA. 1998;95:13363–13383. - PMC - PubMed
    1. Harris DA, True HL. Neuron. 2006;50:353–357. - PubMed
    1. Chernoff YO. Curr Opin Chem Biol. 2004;8:665–671. - PubMed

Publication types

LinkOut - more resources